Coreline Soft has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its aortic quantitative analysis tool, AVIEW Aorta Metrics.
The regulatory clearance brings the company’s total to 13 FDA 510(k) clearances and broadens its chest computed tomography (CT) AI portfolio in the US.
The software automatically segments the aorta using chest CT scans and calculates quantitative diameter measurements throughout anatomical regions.